AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) have been used to treat non-small cell lung carcinoma (NSCLC) patients that have EGFR-activating mutations. EGFR-TKI monotherapy in most NSCLC patients with EGFR mutations who initially respond to EGFR-TKIs results in the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Rep
Auteurs principaux: CHEN, JIA, LU, HUIQI, ZHOU, WANG, YIN, HUABIN, ZHU, LISHUANG, LIU, CHANG, ZHANG, PENGFEI, HU, HUIMIN, YANG, YILI, HAN, HUANXING
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2015
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4440218/
https://ncbi.nlm.nih.gov/pubmed/25634113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2015.3764
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires